Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Lonza 4D-Nucleofector LV Unit PRO electroporation unit

Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...

Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)

The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...

Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms

The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...

Content from other channels on our network

Planning approval for B2B green hydrogen facility

Digital retrofits driving a new era of sustainable buildings

A sustainable approach to increase wastewater recycling

Sustainability commitment key for LAPP Australia MD

NSW Govt supports business to use energy-saving heat pumps

AI scribes resource released amid heightened scrutiny

Robot automates hospital disinfection processes

Heating and cooling systems: advanced features for health care

Colorectal cancer survivors face elevated risk

2025 Australian Mental Health Prize entries open until 23 July

Frozen Logistics: new report reveals cold storage is in short supply

Call for comment on phospholipase C as a processing aid

Tubular cable conveyor system helps to increase production 70% for almond processor

Bonfiglioli to debut new products at Foodtech Packtech

Cheese exporter upgrades inspection system on its grated cheese lines